Last edition
Articles
PRIP Scheme Set for Rollout: Key Highlights of the INR 5,000 Cr Initiative
The PRIP scheme has a total financial outlay of INR 5,000 crore, of which INR 4,250 crore is focused on accelerating investments in the R&D ecosystem within the Pharma MedTech sector....
Recalibrating Pharma after the GST Overhaul
The reform creates an opportunity for the pharma and medical device industry to advance affordable care, expand access to medicines and diagnostics, and improve insurance coverage....
Redesigning Pharma Packaging for Compliance and Sustainability: A Strategic Shift
Pharmaceutical packaging is evolving beyond protection and compliance to focus on traceability, sustainability, patient-centric design, and digital access—driving greater collaboration between pharma companies...
Offline AI: Bringing High-Tech Diagnostics to Low-Resource Settings
For the pharmaceutical and med-tech industries, offline AI represents more than a clinical tool—it serves as a market enabler to identify disease early....
The ESG Imperative for Pharma, Healthcare and Biotech in India
By embedding sustainability in core operations, pharma and biotech companies can reduce risk exposure, unlock operational efficiencies, attract ESG-linked financing, and strengthen public trust....
Articles by category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy